ABSA International
ABSA International

Resources with keywords: covid-19

Training Tools & Resources
EIDC Toolboxes


Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 (Website, Regulatory)
CDC/Health Alert Network (HAN)
25 April 2022
keywords: covid-19, risk factors, senior living, treatment
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
22 April 2022

Shi DS, Whitaker M, Marks KJ, et al.

keywords: children, covid-19, hospitalization, vaccination
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
15 April 2022

Plumb ID, Feldstein LR, Barkley E, et al.

keywords: covid-19, hospitalization, mRNA, vaccines
Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals (Website, Regulatory)
FDA
29 March 2022

The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.

keywords: booster, covid-19, vaccination
Taiwan’s science academy fined for biosafety lapses after lab worker contracts COVID-19 (Website, News)
Science
24 January 2022

A research assistant at an Academia Sinica lab fell ill in November 2021 after working with infected animals

keywords: biosafety, covid-19, lab workers, workplace
COVID-19 Antigen Testing Biosafety Guidance (Document)
Association of Public Health Laboratories (APHL)

This document describes recommended biosafety practices to protect personnel and the work area from contamination with Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when collecting and testing specimens for coronavirus disease 2019 (COVID-19) using an antigen test (ex. BD VeritorTM, Quidel SofiaTM or Abbott BinaxNOW TM ).

keywords: biosafety, covid-19, workplace
Biosafety advisory: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) (Website, Regulatory)
Government of Canada

This recent update includes Classification of full length SARS-CoV-2 RNA as a Risk Group 2 human pathogen and a Risk Group 1 animal pathogen.

keywords: biosafety, covid-19, RNA
Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies (NEW 5/6, Website, Publication)
JAMA
4 April 2022

Ruderman RS, Mormol J, Trawick E, et al

keywords: covid-19, pregnancy, vaccination
How long covid is accelerating a revolution in medical research (NEW 5/6, Website, News)
Washington Post
3 April 2022
keywords: covid-19, Long COVID
COVID-19 (SARS-CoV-2) Special Collection (Website, Publication)
American Society for Microbiology (ASM)

This collection highlights all COVID-19/SARS-CoV-2 research published across ASM Journals. All content is free to read and available for text and data mining via PubMed Central.

keywords: covid-19

Not a member and would like updates and notifications?

ABSA International
1200 Allanson Road, Mundelein, IL 60060-3808
1-866-425-1385 (toll free) or 847-949-1517
info@absa.org | Contact ABSA

ABOUT | MEMBERSHIP | NEWS/COMMUNITY | RESOURCES | PUBLICATIONS | CREDENTIALS | PROFESSIONAL DEVELOPMENT

For a complete view of the web presence of ABSA International, see the ABSA Portal page.

Copyright © ABSA International. All Rights Reserved.  Privacy Policy

ABSA International does not endorse, promote, review, or warrant the accuracy of the products and services offered by those parties who link to the ABSA International website. The links are merely provided as a convenience to the visitors of this site, and ABSA International may or may not be compensated for permitting the link to be displayed on this page.

Go to Top